These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 29698389)

  • 1. Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.
    Zhang RX; Li J; Zhang T; Amini MA; He C; Lu B; Ahmed T; Lip H; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2018 May; 39(5):825-844. PubMed ID: 29698389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy.
    Kang T; Li F; Baik S; Shao W; Ling D; Hyeon T
    Biomaterials; 2017 Aug; 136():98-114. PubMed ID: 28525855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticles based cancer therapy: current status and applications.
    Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
    Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
    Xu J; Liao K; Jiang H; Zhou W
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
    Szebeni J
    Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
    Luo W; Zhang T
    Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.
    Chen Z; Wang X; Zhao N; Chen H; Guo G
    Expert Opin Drug Deliv; 2023; 20(11):1623-1642. PubMed ID: 38059646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An arsenal of magnetic nanoparticles; perspectives in the treatment of cancer.
    Karponis D; Azzawi M; Seifalian A
    Nanomedicine (Lond); 2016 Aug; 11(16):2215-32. PubMed ID: 27480599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
    Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
    J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology platforms; an innovative approach to brain tumor therapy.
    Nair BG; Varghese SH; Nair R; Yoshida Y; Maekawa T; Kumar DS
    Med Chem; 2011 Sep; 7(5):488-503. PubMed ID: 21801148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs.
    Ahmed T; Liu FF; Lu B; Lip H; Park E; Alradwan I; Liu JF; He C; Zetrini A; Zhang T; Ghavaminejad A; Rauth AM; Henderson JT; Wu XY
    Mol Pharm; 2022 Jun; 19(6):1722-1765. PubMed ID: 35587783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance.
    Liu J; Ma X; Jin S; Xue X; Zhang C; Wei T; Guo W; Liang XJ
    Mol Pharm; 2016 May; 13(5):1723-30. PubMed ID: 27070828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
    Chakraborty S; Dhakshinamurthy GS; Misra SK
    J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.